Young-Sun Sohn
Corporate Officer/Principal bij Catholic University of Korea
Actieve functies van Young-Sun Sohn
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Catholic University of Korea | Corporate Officer/Principal | 15-09-2011 | - |
Loopbaan van Young-Sun Sohn
Eerdere bekende functies van Young-Sun Sohn
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Abxign, Inc.
Abxign, Inc. Pharmaceuticals: MajorHealth Technology Abxign, Inc. was established in January 2008 and is located in Samsung Cancer Research building in Seoul National University. Abxign focused on the discovery and development of antibody therapeutics where by first or best-in-class therapies are introduced in large and growing markets with quality partners. Abxign has accumulated therapeutic antibody development technology and experience for many years and maintains relationships with domestic and foreign pharmaceutical companies specialized for each part of the development of antibody therapy. Based on these Abxign's network and technology, it will release the excellent antibodies in the world pharmaceutical market and extend the human life and contribute to improving the quality of life. | President | 15-09-2011 | 25-07-2013 |
CJ CORPORATION | Hoofd Techniek/Wetenschap/O&O | - | - |
DAEWOONG PHARMACEUTICAL CO., LTD | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
Zuid-Korea | 5 |
Operationeel
Corporate Officer/Principal | 2 |
President | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Consumer Non-Durables | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
DAEWOONG PHARMACEUTICAL CO., LTD | Health Technology |
CJ CORPORATION | Consumer Non-Durables |
Bedrijven in privébezit | 1 |
---|---|
Abxign, Inc.
Abxign, Inc. Pharmaceuticals: MajorHealth Technology Abxign, Inc. was established in January 2008 and is located in Samsung Cancer Research building in Seoul National University. Abxign focused on the discovery and development of antibody therapeutics where by first or best-in-class therapies are introduced in large and growing markets with quality partners. Abxign has accumulated therapeutic antibody development technology and experience for many years and maintains relationships with domestic and foreign pharmaceutical companies specialized for each part of the development of antibody therapy. Based on these Abxign's network and technology, it will release the excellent antibodies in the world pharmaceutical market and extend the human life and contribute to improving the quality of life. | Health Technology |
- Beurs
- Insiders
- Young-Sun Sohn
- Ervaring